aluates Reports

$ 0.0

Automative

Conjunctivitis- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Published Date: August 2025

Report Code: QYRE-Auto-10L316

Global Conjunctivitis Market Insights and Forecast to 2028

BUY CHAPTERS

Conjunctivitis- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Code: QYRE-Auto-10L316

Report

August 2025

Pages:92

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Novartis (CH)

Santen Pharmaceutical (JP)

Bausch& Lomb (US)

Allergan(US)

Sun Pharmaceutical (ID)

Akorn (US)

Freda (CN)

Sinqi (CN)

Univision (CN)

Bausch& Lomb (US)

Conjunctivitis- Market Size

The global market for Conjunctivitis was estimated to be worth US$ 3674 million in 2024 and is forecast to a readjusted size of US$ 4099 million by 2031 with a CAGR of 1.6% during the forecast period 2025-2031.

Conjunctivitis- Market

Conjunctivitis, or inflammation of the conjunctiva, is a general term that refers to a diverse group of diseases/disorders that affect the conjunctiva primarily. Most varieties of conjunctivitis are self-limited, but some progress and may cause serious ocular and extraocular complications.

Conjunctivitis is more commonly referred to as pink eye. The whites of the eyes appear pink or red when the conjunctiva (the transparent membrane which lines part of the eyeball) becomes inflamed or infected.

The technical barriers of conjunctivitis industry are existed apparently. The key technology and higher level products are in the hand of the global leading enterprise like Novartis, Santen Pharmaceutical, Bausch + Lomb, Allergan, Sun Pharmaceutical, Akorn and Sinqi, etc.

This report aims to provide a comprehensive presentation of the global market for Conjunctivitis, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Conjunctivitis by region & country, by Type, and by End User.

The Conjunctivitis market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Conjunctivitis.

Market Segmentation

Scope of Conjunctivitis- Market Report

Report Metric	Details
Report Name	Conjunctivitis- Market
Forecasted market size in 2031	US$ 4099 million
CAGR	1.6%
Forecasted years	2025 - 2031
Segment by Type	Antibiotic Pills Ointment
Segment by End User	Newborns Children Adults
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Novartis (CH), Santen Pharmaceutical (JP), Bausch & Lomb (US), Allergan (US), Sun Pharmaceutical (ID), Akorn (US), Freda (CN), Sinqi (CN), Univision (CN)
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Conjunctivitis manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by End User, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Conjunctivitis in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Conjunctivitis in country level. It provides sigmate data by Type, and by End User for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Conjunctivitis- Market size in 2031?

Ans: The Conjunctivitis- Market size in 2031 will be US$ 4099 million.

Who are the main players in the Conjunctivitis- Market report?

Ans: The main players in the Conjunctivitis- Market are Novartis (CH), Santen Pharmaceutical (JP), Bausch & Lomb (US), Allergan (US), Sun Pharmaceutical (ID), Akorn (US), Freda (CN), Sinqi (CN), Univision (CN)

What are the Type segmentation covered in the Conjunctivitis- Market report?

Ans: The Types covered in the Conjunctivitis- Market report are Antibiotic, Pills, Ointment

What are the End User segmentation covered in the Conjunctivitis- Market report?

Ans: The End users covered in the Conjunctivitis- Market report are Newborns, Children, Adults

1 Market Overview

1.1 Conjunctivitis Product Introduction

1.2 Global Conjunctivitis Market Size Forecast

1.2.1 Global Conjunctivitis Sales Value (2020-2031)

1.2.2 Global Conjunctivitis Sales Volume (2020-2031)

1.2.3 Global Conjunctivitis Sales Price (2020-2031)

1.3 Conjunctivitis Market Trends & Drivers

1.3.1 Conjunctivitis Industry Trends

1.3.2 Conjunctivitis Market Drivers & Opportunity

1.3.3 Conjunctivitis Market Challenges

1.3.4 Conjunctivitis Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Conjunctivitis Players Revenue Ranking (2024)

2.2 Global Conjunctivitis Revenue by Company (2020-2025)

2.3 Global Conjunctivitis Players Sales Volume Ranking (2024)

2.4 Global Conjunctivitis Sales Volume by Company Players (2020-2025)

2.5 Global Conjunctivitis Average Price by Company (2020-2025)

2.6 Key Manufacturers Conjunctivitis Manufacturing Base and Headquarters

2.7 Key Manufacturers Conjunctivitis Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Conjunctivitis

2.9 Conjunctivitis Market Competitive Analysis

2.9.1 Conjunctivitis Market Concentration Rate (2020-2025)

2.9.2 Global 5 and 10 Largest Manufacturers by Conjunctivitis Revenue in 2024

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Conjunctivitis as of 2024)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Antibiotic

3.1.2 Pills

3.1.3 Ointment

3.2 Global Conjunctivitis Sales Value by Type

3.2.1 Global Conjunctivitis Sales Value by Type (2020 VS 2024 VS 2031)

3.2.2 Global Conjunctivitis Sales Value, by Type (2020-2031)

3.2.3 Global Conjunctivitis Sales Value, by Type (%) (2020-2031)

3.3 Global Conjunctivitis Sales Volume by Type

3.3.1 Global Conjunctivitis Sales Volume by Type (2020 VS 2024 VS 2031)

3.3.2 Global Conjunctivitis Sales Volume, by Type (2020-2031)

3.3.3 Global Conjunctivitis Sales Volume, by Type (%) (2020-2031)

3.4 Global Conjunctivitis Average Price by Type (2020-2031)

4 Segmentation by End User

4.1 Introduction by End User

4.1.1 Newborns

4.1.2 Children

4.1.3 Adults

4.2 Global Conjunctivitis Sales Value by End User

4.2.1 Global Conjunctivitis Sales Value by End User (2020 VS 2024 VS 2031)

4.2.2 Global Conjunctivitis Sales Value, by End User (2020-2031)

4.2.3 Global Conjunctivitis Sales Value, by End User (%) (2020-2031)

4.3 Global Conjunctivitis Sales Volume by End User

4.3.1 Global Conjunctivitis Sales Volume by End User (2020 VS 2024 VS 2031)

4.3.2 Global Conjunctivitis Sales Volume, by End User (2020-2031)

4.3.3 Global Conjunctivitis Sales Volume, by End User (%) (2020-2031)

4.4 Global Conjunctivitis Average Price by End User (2020-2031)

5 Segmentation by Region

5.1 Global Conjunctivitis Sales Value by Region

5.1.1 Global Conjunctivitis Sales Value by Region: 2020 VS 2024 VS 2031

5.1.2 Global Conjunctivitis Sales Value by Region (2020-2025)

5.1.3 Global Conjunctivitis Sales Value by Region (2026-2031)

5.1.4 Global Conjunctivitis Sales Value by Region (%), (2020-2031)

5.2 Global Conjunctivitis Sales Volume by Region

5.2.1 Global Conjunctivitis Sales Volume by Region: 2020 VS 2024 VS 2031

5.2.2 Global Conjunctivitis Sales Volume by Region (2020-2025)

5.2.3 Global Conjunctivitis Sales Volume by Region (2026-2031)

5.2.4 Global Conjunctivitis Sales Volume by Region (%), (2020-2031)

5.3 Global Conjunctivitis Average Price by Region (2020-2031)

5.4 North America

5.4.1 North America Conjunctivitis Sales Value, 2020-2031

5.4.2 North America Conjunctivitis Sales Value by Country (%), 2024 VS 2031

5.5 Europe

5.5.1 Europe Conjunctivitis Sales Value, 2020-2031

5.5.2 Europe Conjunctivitis Sales Value by Country (%), 2024 VS 2031

5.6 Asia Pacific

5.6.1 Asia Pacific Conjunctivitis Sales Value, 2020-2031

5.6.2 Asia Pacific Conjunctivitis Sales Value by Region (%), 2024 VS 2031

5.7 South America

5.7.1 South America Conjunctivitis Sales Value, 2020-2031

5.7.2 South America Conjunctivitis Sales Value by Country (%), 2024 VS 2031

5.8 Middle East & Africa

5.8.1 Middle East & Africa Conjunctivitis Sales Value, 2020-2031

5.8.2 Middle East & Africa Conjunctivitis Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Conjunctivitis Sales Value Growth Trends, 2020 VS 2024 VS 2031

6.2 Key Countries/Regions Conjunctivitis Sales Value

6.2.1 Key Countries/Regions Conjunctivitis Sales Value, 2020-2031

6.2.2 Key Countries/Regions Conjunctivitis Sales Volume, 2020-2031

6.3 United States

6.3.1 United States Conjunctivitis Sales Value, 2020-2031

6.3.2 United States Conjunctivitis Sales Value by Type (%), 2024 VS 2031

6.3.3 United States Conjunctivitis Sales Value by End User, 2024 VS 2031

6.4 Europe

6.4.1 Europe Conjunctivitis Sales Value, 2020-2031

6.4.2 Europe Conjunctivitis Sales Value by Type (%), 2024 VS 2031

6.4.3 Europe Conjunctivitis Sales Value by End User, 2024 VS 2031

6.5 China

6.5.1 China Conjunctivitis Sales Value, 2020-2031

6.5.2 China Conjunctivitis Sales Value by Type (%), 2024 VS 2031

6.5.3 China Conjunctivitis Sales Value by End User, 2024 VS 2031

6.6 Japan

6.6.1 Japan Conjunctivitis Sales Value, 2020-2031

6.6.2 Japan Conjunctivitis Sales Value by Type (%), 2024 VS 2031

6.6.3 Japan Conjunctivitis Sales Value by End User, 2024 VS 2031

6.7 South Korea

6.7.1 South Korea Conjunctivitis Sales Value, 2020-2031

6.7.2 South Korea Conjunctivitis Sales Value by Type (%), 2024 VS 2031

6.7.3 South Korea Conjunctivitis Sales Value by End User, 2024 VS 2031

6.8 Southeast Asia

6.8.1 Southeast Asia Conjunctivitis Sales Value, 2020-2031

6.8.2 Southeast Asia Conjunctivitis Sales Value by Type (%), 2024 VS 2031

6.8.3 Southeast Asia Conjunctivitis Sales Value by End User, 2024 VS 2031

6.9 India

6.9.1 India Conjunctivitis Sales Value, 2020-2031

6.9.2 India Conjunctivitis Sales Value by Type (%), 2024 VS 2031

6.9.3 India Conjunctivitis Sales Value by End User, 2024 VS 2031

7 Company Profiles

7.1 Novartis (CH)

7.1.1 Novartis (CH) Company Information

7.1.2 Novartis (CH) Introduction and Business Overview

7.1.3 Novartis (CH) Conjunctivitis Sales, Revenue, Price and Gross Margin (2020-2025)

7.1.4 Novartis (CH) Conjunctivitis Product Offerings

7.1.5 Novartis (CH) Recent Development

7.2 Santen Pharmaceutical (JP)

7.2.1 Santen Pharmaceutical (JP) Company Information

7.2.2 Santen Pharmaceutical (JP) Introduction and Business Overview

7.2.3 Santen Pharmaceutical (JP) Conjunctivitis Sales, Revenue, Price and Gross Margin (2020-2025)

7.2.4 Santen Pharmaceutical (JP) Conjunctivitis Product Offerings

7.2.5 Santen Pharmaceutical (JP) Recent Development

7.3 Bausch & Lomb (US)

7.3.1 Bausch & Lomb (US) Company Information

7.3.2 Bausch & Lomb (US) Introduction and Business Overview

7.3.3 Bausch & Lomb (US) Conjunctivitis Sales, Revenue, Price and Gross Margin (2020-2025)

7.3.4 Bausch & Lomb (US) Conjunctivitis Product Offerings

7.3.5 Bausch & Lomb (US) Recent Development

7.4 Allergan (US)

7.4.1 Allergan (US) Company Information

7.4.2 Allergan (US) Introduction and Business Overview

7.4.3 Allergan (US) Conjunctivitis Sales, Revenue, Price and Gross Margin (2020-2025)

7.4.4 Allergan (US) Conjunctivitis Product Offerings

7.4.5 Allergan (US) Recent Development

7.5 Sun Pharmaceutical (ID)

7.5.1 Sun Pharmaceutical (ID) Company Information

7.5.2 Sun Pharmaceutical (ID) Introduction and Business Overview

7.5.3 Sun Pharmaceutical (ID) Conjunctivitis Sales, Revenue, Price and Gross Margin (2020-2025)

7.5.4 Sun Pharmaceutical (ID) Conjunctivitis Product Offerings

7.5.5 Sun Pharmaceutical (ID) Recent Development

7.6 Akorn (US)

7.6.1 Akorn (US) Company Information

7.6.2 Akorn (US) Introduction and Business Overview

7.6.3 Akorn (US) Conjunctivitis Sales, Revenue, Price and Gross Margin (2020-2025)

7.6.4 Akorn (US) Conjunctivitis Product Offerings

7.6.5 Akorn (US) Recent Development

7.7 Freda (CN)

7.7.1 Freda (CN) Company Information

7.7.2 Freda (CN) Introduction and Business Overview

7.7.3 Freda (CN) Conjunctivitis Sales, Revenue, Price and Gross Margin (2020-2025)

7.7.4 Freda (CN) Conjunctivitis Product Offerings

7.7.5 Freda (CN) Recent Development

7.8 Sinqi (CN)

7.8.1 Sinqi (CN) Company Information

7.8.2 Sinqi (CN) Introduction and Business Overview

7.8.3 Sinqi (CN) Conjunctivitis Sales, Revenue, Price and Gross Margin (2020-2025)

7.8.4 Sinqi (CN) Conjunctivitis Product Offerings

7.8.5 Sinqi (CN) Recent Development

7.9 Univision (CN)

7.9.1 Univision (CN) Company Information

7.9.2 Univision (CN) Introduction and Business Overview

7.9.3 Univision (CN) Conjunctivitis Sales, Revenue, Price and Gross Margin (2020-2025)

7.9.4 Univision (CN) Conjunctivitis Product Offerings

7.9.5 Univision (CN) Recent Development

8 Industry Chain Analysis

8.1 Conjunctivitis Industrial Chain

8.2 Conjunctivitis Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Conjunctivitis Sales Model

8.5.2 Sales Channel

8.5.3 Conjunctivitis Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Novartis (CH)

Santen Pharmaceutical (JP)

Bausch& Lomb (US)

Allergan(US)

Sun Pharmaceutical (ID)

Akorn (US)

Freda (CN)

Sinqi (CN)

Univision (CN)

Bausch& Lomb (US)

List of Tables

Table 1. Conjunctivitis Market Trends

Table 2. Conjunctivitis Market Drivers & Opportunity

Table 3. Conjunctivitis Market Challenges

Table 4. Conjunctivitis Market Restraints

Table 5. Global Conjunctivitis Revenue by Company (2020-2025) & (US$ Million)

Table 6. Global Conjunctivitis Revenue Market Share by Company (2020-2025)

Table 7. Global Conjunctivitis Sales Volume by Company (2020-2025) & (K Units)

Table 8. Global Conjunctivitis Sales Volume Market Share by Company (2020-2025)

Table 9. Global Market Conjunctivitis Price by Company (2020-2025) & (USD/Unit)

Table 10. Key Manufacturers Conjunctivitis Manufacturing Base and Headquarters

Table 11. Key Manufacturers Conjunctivitis Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Conjunctivitis

Table 13. Global Conjunctivitis Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Conjunctivitis as of 2024)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Conjunctivitis Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)

Table 17. Global Conjunctivitis Sales Value by Type (2020-2025) & (US$ Million)

Table 18. Global Conjunctivitis Sales Value by Type (2026-2031) & (US$ Million)

Table 19. Global Conjunctivitis Sales Market Share in Value by Type (2020-2025)

Table 20. Global Conjunctivitis Sales Market Share in Value by Type (2026-2031)

Table 21. Global Conjunctivitis Sales Volume by Type: 2020 VS 2024 VS 2031 (K Units)

Table 22. Global Conjunctivitis Sales Volume by Type (2020-2025) & (K Units)

Table 23. Global Conjunctivitis Sales Volume by Type (2026-2031) & (K Units)

Table 24. Global Conjunctivitis Sales Market Share in Volume by Type (2020-2025)

Table 25. Global Conjunctivitis Sales Market Share in Volume by Type (2026-2031)

Table 26. Global Conjunctivitis Price by Type (2020-2025) & (USD/Unit)

Table 27. Global Conjunctivitis Price by Type (2026-2031) & (USD/Unit)

Table 28. Global Conjunctivitis Sales Value by End User: 2020 VS 2024 VS 2031 (US$ Million)

Table 29. Global Conjunctivitis Sales Value by End User (2020-2025) & (US$ Million)

Table 30. Global Conjunctivitis Sales Value by End User (2026-2031) & (US$ Million)

Table 31. Global Conjunctivitis Sales Market Share in Value by End User (2020-2025)

Table 32. Global Conjunctivitis Sales Market Share in Value by End User (2026-2031)

Table 33. Global Conjunctivitis Sales Volume by End User: 2020 VS 2024 VS 2031 (K Units)

Table 34. Global Conjunctivitis Sales Volume by End User (2020-2025) & (K Units)

Table 35. Global Conjunctivitis Sales Volume by End User (2026-2031) & (K Units)

Table 36. Global Conjunctivitis Sales Market Share in Volume by End User (2020-2025)

Table 37. Global Conjunctivitis Sales Market Share in Volume by End User (2026-2031)

Table 38. Global Conjunctivitis Price by End User (2020-2025) & (USD/Unit)

Table 39. Global Conjunctivitis Price by End User (2026-2031) & (USD/Unit)

Table 40. Global Conjunctivitis Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)

Table 41. Global Conjunctivitis Sales Value by Region (2020-2025) & (US$ Million)

Table 42. Global Conjunctivitis Sales Value by Region (2026-2031) & (US$ Million)

Table 43. Global Conjunctivitis Sales Value by Region (2020-2025) & (%)

Table 44. Global Conjunctivitis Sales Value by Region (2026-2031) & (%)

Table 45. Global Conjunctivitis Sales Volume by Region (K Units): 2020 VS 2024 VS 2031

Table 46. Global Conjunctivitis Sales Volume by Region (2020-2025) & (K Units)

Table 47. Global Conjunctivitis Sales Volume by Region (2026-2031) & (K Units)

Table 48. Global Conjunctivitis Sales Volume by Region (2020-2025) & (%)

Table 49. Global Conjunctivitis Sales Volume by Region (2026-2031) & (%)

Table 50. Global Conjunctivitis Average Price by Region (2020-2025) & (USD/Unit)

Table 51. Global Conjunctivitis Average Price by Region (2026-2031) & (USD/Unit)

Table 52. Key Countries/Regions Conjunctivitis Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031

Table 53. Key Countries/Regions Conjunctivitis Sales Value, (2020-2025) & (US$ Million)

Table 54. Key Countries/Regions Conjunctivitis Sales Value, (2026-2031) & (US$ Million)

Table 55. Key Countries/Regions Conjunctivitis Sales Volume, (2020-2025) & (K Units)

Table 56. Key Countries/Regions Conjunctivitis Sales Volume, (2026-2031) & (K Units)

Table 57. Novartis (CH) Company Information

Table 58. Novartis (CH) Introduction and Business Overview

Table 59. Novartis (CH) Conjunctivitis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 60. Novartis (CH) Conjunctivitis Product Offerings

Table 61. Novartis (CH) Recent Development

Table 62. Santen Pharmaceutical (JP) Company Information

Table 63. Santen Pharmaceutical (JP) Introduction and Business Overview

Table 64. Santen Pharmaceutical (JP) Conjunctivitis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 65. Santen Pharmaceutical (JP) Conjunctivitis Product Offerings

Table 66. Santen Pharmaceutical (JP) Recent Development

Table 67. Bausch & Lomb (US) Company Information

Table 68. Bausch & Lomb (US) Introduction and Business Overview

Table 69. Bausch & Lomb (US) Conjunctivitis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 70. Bausch & Lomb (US) Conjunctivitis Product Offerings

Table 71. Bausch & Lomb (US) Recent Development

Table 72. Allergan (US) Company Information

Table 73. Allergan (US) Introduction and Business Overview

Table 74. Allergan (US) Conjunctivitis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 75. Allergan (US) Conjunctivitis Product Offerings

Table 76. Allergan (US) Recent Development

Table 77. Sun Pharmaceutical (ID) Company Information

Table 78. Sun Pharmaceutical (ID) Introduction and Business Overview

Table 79. Sun Pharmaceutical (ID) Conjunctivitis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 80. Sun Pharmaceutical (ID) Conjunctivitis Product Offerings

Table 81. Sun Pharmaceutical (ID) Recent Development

Table 82. Akorn (US) Company Information

Table 83. Akorn (US) Introduction and Business Overview

Table 84. Akorn (US) Conjunctivitis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 85. Akorn (US) Conjunctivitis Product Offerings

Table 86. Akorn (US) Recent Development

Table 87. Freda (CN) Company Information

Table 88. Freda (CN) Introduction and Business Overview

Table 89. Freda (CN) Conjunctivitis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 90. Freda (CN) Conjunctivitis Product Offerings

Table 91. Freda (CN) Recent Development

Table 92. Sinqi (CN) Company Information

Table 93. Sinqi (CN) Introduction and Business Overview

Table 94. Sinqi (CN) Conjunctivitis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 95. Sinqi (CN) Conjunctivitis Product Offerings

Table 96. Sinqi (CN) Recent Development

Table 97. Univision (CN) Company Information

Table 98. Univision (CN) Introduction and Business Overview

Table 99. Univision (CN) Conjunctivitis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 100. Univision (CN) Conjunctivitis Product Offerings

Table 101. Univision (CN) Recent Development

Table 102. Key Raw Materials Lists

Table 103. Raw Materials Key Suppliers Lists

Table 104. Conjunctivitis Downstream Customers

Table 105. Conjunctivitis Distributors List

Table 106. Research Programs/Design for This Report

Table 107. Key Data Information from Secondary Sources

Table 108. Key Data Information from Primary Sources

List of Figures

Figure 1. Conjunctivitis Product Picture

Figure 2. Global Conjunctivitis Sales Value, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Global Conjunctivitis Sales Value (2020-2031) & (US$ Million)

Figure 4. Global Conjunctivitis Sales Volume (2020-2031) & (K Units)

Figure 5. Global Conjunctivitis Sales Price (2020-2031) & (USD/Unit)

Figure 6. Conjunctivitis Report Years Considered

Figure 7. Global Conjunctivitis Players Revenue Ranking (2024) & (US$ Million)

Figure 8. Global Conjunctivitis Players Sales Volume Ranking (2024) & (K Units)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Conjunctivitis Revenue in 2024

Figure 10. Conjunctivitis Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 11. Antibiotic Picture

Figure 12. Pills Picture

Figure 13. Ointment Picture

Figure 14. Global Conjunctivitis Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)

Figure 15. Global Conjunctivitis Sales Value Market Share by Type, 2024 & 2031

Figure 16. Global Conjunctivitis Sales Volume by Type (2020 VS 2024 VS 2031) & (K Units)

Figure 17. Global Conjunctivitis Sales Volume Market Share by Type, 2024 & 2031

Figure 18. Global Conjunctivitis Price by Type (2020-2031) & (USD/Unit)

Figure 19. Product Picture of Newborns

Figure 20. Product Picture of Children

Figure 21. Product Picture of Adults

Figure 22. Global Conjunctivitis Sales Value by End User (2020 VS 2024 VS 2031) & (US$ Million)

Figure 23. Global Conjunctivitis Sales Value Market Share by End User, 2024 & 2031

Figure 24. Global Conjunctivitis Sales Volume by End User (2020 VS 2024 VS 2031) & (K Units)

Figure 25. Global Conjunctivitis Sales Volume Market Share by End User, 2024 & 2031

Figure 26. Global Conjunctivitis Price by End User (2020-2031) & (USD/Unit)

Figure 27. North America Conjunctivitis Sales Value (2020-2031) & (US$ Million)

Figure 28. North America Conjunctivitis Sales Value by Country (%), 2024 VS 2031

Figure 29. Europe Conjunctivitis Sales Value, (2020-2031) & (US$ Million)

Figure 30. Europe Conjunctivitis Sales Value by Country (%), 2024 VS 2031

Figure 31. Asia Pacific Conjunctivitis Sales Value, (2020-2031) & (US$ Million)

Figure 32. Asia Pacific Conjunctivitis Sales Value by Region (%), 2024 VS 2031

Figure 33. South America Conjunctivitis Sales Value, (2020-2031) & (US$ Million)

Figure 34. South America Conjunctivitis Sales Value by Country (%), 2024 VS 2031

Figure 35. Middle East & Africa Conjunctivitis Sales Value, (2020-2031) & (US$ Million)

Figure 36. Middle East & Africa Conjunctivitis Sales Value by Country (%), 2024 VS 2031

Figure 37. Key Countries/Regions Conjunctivitis Sales Value (%), (2020-2031)

Figure 38. Key Countries/Regions Conjunctivitis Sales Volume (%), (2020-2031)

Figure 39. United States Conjunctivitis Sales Value, (2020-2031) & (US$ Million)

Figure 40. United States Conjunctivitis Sales Value by Type (%), 2024 VS 2031

Figure 41. United States Conjunctivitis Sales Value by End User (%), 2024 VS 2031

Figure 42. Europe Conjunctivitis Sales Value, (2020-2031) & (US$ Million)

Figure 43. Europe Conjunctivitis Sales Value by Type (%), 2024 VS 2031

Figure 44. Europe Conjunctivitis Sales Value by End User (%), 2024 VS 2031

Figure 45. China Conjunctivitis Sales Value, (2020-2031) & (US$ Million)

Figure 46. China Conjunctivitis Sales Value by Type (%), 2024 VS 2031

Figure 47. China Conjunctivitis Sales Value by End User (%), 2024 VS 2031

Figure 48. Japan Conjunctivitis Sales Value, (2020-2031) & (US$ Million)

Figure 49. Japan Conjunctivitis Sales Value by Type (%), 2024 VS 2031

Figure 50. Japan Conjunctivitis Sales Value by End User (%), 2024 VS 2031

Figure 51. South Korea Conjunctivitis Sales Value, (2020-2031) & (US$ Million)

Figure 52. South Korea Conjunctivitis Sales Value by Type (%), 2024 VS 2031

Figure 53. South Korea Conjunctivitis Sales Value by End User (%), 2024 VS 2031

Figure 54. Southeast Asia Conjunctivitis Sales Value, (2020-2031) & (US$ Million)

Figure 55. Southeast Asia Conjunctivitis Sales Value by Type (%), 2024 VS 2031

Figure 56. Southeast Asia Conjunctivitis Sales Value by End User (%), 2024 VS 2031

Figure 57. India Conjunctivitis Sales Value, (2020-2031) & (US$ Million)

Figure 58. India Conjunctivitis Sales Value by Type (%), 2024 VS 2031

Figure 59. India Conjunctivitis Sales Value by End User (%), 2024 VS 2031

Figure 60. Conjunctivitis Industrial Chain

Figure 61. Conjunctivitis Manufacturing Cost Structure

Figure 62. Channels of Distribution (Direct Sales, and Distribution)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Inflammatory Eye Diseases Treatment Market Research Report 2025

Allergic Conjunctivitis Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Allergic Conjunctivitis Treatments Market Research Report 2024

Global Conjunctivitis Treatment Eye Drops Market Research Report 2024

Ocular Inflammation Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Allergic Conjunctivitis Drug Market Research Report 2024

Ocular Allergy Diagnostic Systems Market

Global Blepharitis Drugs Market Insights Forecast to 2030

Global Ophthalmic Anti inflammatories Market Research Report 2025

Global Eye Allergy Therapeutics Market Insights Forecast to 2030

Panuveitis Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Drugs for Ophthalmology Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Blepharitis Therapeutics Market Research Report 2025

Global Rhinoconjunctivitis Market Research Report 2024

Global Sudden Eye Pain Relief Treatment Market Research Report 2024

Blepharitis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Ophthalmology Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Retinitis Pigmentosa Retinitis Market Insights Forecast to 2030

Ophthalmology Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global High Acuity Care Service Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-5D18285

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global mHealth (Mobile Health) Services Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-18B6151

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Resin Lenses Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-21S7871

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Mobile Medical Imaging Services Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-16Q6154

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions